Drug pricing review group signs deal with Aetion for patient data

Drug pricing review group signs deal with Aetion for patient data

Reuters

Published

The Institute for Clinical and Economic Review (ICER), a small but influential Boston-based research group, has signed a deal with private technology company Aetion to help it use patient health data in its reports on whether individual drugs are priced properly.

Full Article